Clinical trial
Targeted Temporary In Situ Catheter Redosing of Autonomic Neural Blockade for Breakthrough Symptoms After Laparoscopic Sleeve Gastrectomy
NCT07655908 is registered in ClinicalTrials.gov with Universidad Simón Bolívar as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Targeted Temporary In Situ Catheter Redosing of Autonomic Neural Blockade for Breakthrough Symptoms After Laparoscopic Sleeve Gastrectomy
- Lead sponsor
- Universidad Simón Bolívar
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- June 15, 2026
- Completion date
- February 28, 2027
- Enrollment
- 30 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
nausea and vomiting, postoperative, pain, acute post-operative